Mario G. Roberts’s passion for investment was primed after working in a finance firm far back in 2002. In the last 14 years, he has been an investment analyst committed to research and development of strategies that have been found resourceful and successful.
Author of Discovering the Pattern a book for investors interested in taking advantage if seasonal swings in the market to double their portfolio performance.
I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach.
I provide consulting to clients, both the retail and professional investors. I accurately forecasted many clinical trials, such as the Flint Trials for Intercept, the Ascend Trials for InterMune and the Affinity Trials MannKind, just to name a few. Through Vincata Enterprises, LLC, I helped many clients to unlock substantial values for their investments.
As an expert in biopharmaceutical analysis, I am also more than capable of analyzing any other industries. Though not shown on Seeking Alpha, I have picked an aggregate basket of outperforming stocks.
Investing in biotech is highly risky, but it can be quite rewarding when investors have an edge in data analysis. Physicians who are rigidly scientific tend to lack the analytical prowess of financial experts. Conversely, financiers usually do not possess a physician’s medical expertise. Likewise, scientists are skillful in data analysis; yet they might not be familiar with a physician’s prescribing patterns, which is a requisite to successful biotech investing.
You can visit my website at https://www.retailinvestor360.com for business inquiry.
I am a wedding planner living in the Vancouver B.C. area who became environmentally aware as a result of the oil spill in the Gulf Region. I believe the world must end its dependency on oil and I look for investments that are home runs in solar, clean tech, wind energy and technology.
"Truly conservative actions arise from intelligent hypotheses, correct facts and sound reasoning." - Warren Buffett January 18th 1965.
Furbonacci is an equity research collaborative in Cranston, RI. We run fundamental value screens followed by technical screens to identify equities that may be at significant turning points. Fundamental research is primarily done by reading past annual reports and quarterly statements. Technical analysis is performed on multiple time frames to identify key support and resistance levels, trends and potential turning points. Co-founder Joseph Agresti graduated with a degree in Finance from the University of Connecticut and was employed in 2007-2008 as a prop trader for Chimera Securities in Boston, MA. Co-founder Carl Jetty has an undergraduate degree in Applied Economics from the University of Rhode Island, where his passion for Technical Analysis was first discovered and developed.